Side	side	O	O
effects	effects	O	O
of	of	O	O
postoperative	postoperative	O	O
administration	administration	O	O
of	of	O	O
methylprednisolone	methylprednisolone	S_chemical	O
and	and	O	O
gentamicin	gentamicin	S_chemical	O
into	into	O	O
the	the	O	O
posterior	posterior	O	O
sub-Tenon	sub-tenon	O	O
's	's	O	O
space	space	O	O
.	.	O	O

PURPOSE	purpose	O	O
:	:	O	O
To	to	O	O
assess	assess	O	O
the	the	O	O
incidence	incidence	O	O
of	of	O	O
postoperative	postoperative	O	O
emetic	emetic	O	O
side	side	O	O
effects	effects	O	O
after	after	O	O
the	the	O	O
administration	administration	O	O
of	of	O	O
methylprednisolone	methylprednisolone	S_chemical	O
and	and	O	O
gentamicin	gentamicin	S_chemical	O
into	into	O	O
the	the	O	O
posterior	posterior	O	O
sub-Tenon	sub-tenon	O	O
's	's	O	O
space	space	O	O
at	at	O	O
the	the	O	O
end	end	O	O
of	of	O	O
routine	routine	O	O
cataract	cataract	O	S_disease
surgery	surgery	O	O
.	.	O	O

SETTING	setting	O	O
:	:	O	O
St.	st.	O	O
Luke	luke	O	O
's	's	O	O
Hospital	hospital	O	O
,	,	O	O
Gwardamangia	gwardamangia	O	O
,	,	O	O
Malta	malta	O	O
.	.	O	O

METHODS	methods	O	O
:	:	O	O
A	a	O	O
double-blind	double-blind	O	O
double-armed	double-armed	O	O
prospective	prospective	O	O
study	study	O	O
comprised	comprised	O	O
40	40	O	O
patients	patients	O	O
who	who	O	O
had	had	O	O
uneventful	uneventful	O	O
sutureless	sutureless	O	O
phacoemulsification	phacoemulsification	O	O
under	under	O	O
sub-Tenon	sub-tenon	O	O
's	's	O	O
local	local	O	O
infiltration	infiltration	O	O
of	of	O	O
3	3	O	O
mL	ml	O	O
of	of	O	O
plain	plain	O	O
lignocaine	lignocaine	S_chemical	O
.	.	O	O

At	at	O	O
the	the	O	O
end	end	O	O
of	of	O	O
the	the	O	O
procedure	procedure	O	O
,	,	O	O
Group	group	O	O
A	a	O	O
(	(	O	O
n	n	O	O
=	=	O	O
20	20	O	O
)	)	O	O
had	had	O	O
20	20	O	O
mg/0.5	mg/0.5	O	O
mL	ml	O	O
of	of	O	O
methylprednisolone	methylprednisolone	S_chemical	O
and	and	O	O
10	10	O	O
mg/0.5	mg/0.5	O	O
mL	ml	O	O
of	of	O	O
gentamicin	gentamicin	S_chemical	O
injected	injected	O	O
into	into	O	O
the	the	O	O
posterior	posterior	O	O
sub-Tenon	sub-tenon	O	O
's	's	O	O
space	space	O	O
and	and	O	O
Group	group	O	O
B	b	O	O
(	(	O	O
n	n	O	O
=	=	O	O
20	20	O	O
)	)	O	O
had	had	O	O
the	the	O	O
same	same	O	O
combination	combination	O	O
injected	injected	O	O
into	into	O	O
the	the	O	O
anterior	anterior	O	O
sub-Tenon	sub-tenon	O	O
's	's	O	O
space	space	O	O
.	.	O	O

Postoperatively	postoperatively	O	O
,	,	O	O
all	all	O	O
patients	patients	O	O
were	were	O	O
assessed	assessed	O	O
for	for	O	O
symptoms	symptoms	O	O
of	of	O	O
nausea	nausea	O	S_disease
,	,	O	O
vomiting	vomiting	O	S_disease
,	,	O	O
and	and	O	O
headache	headache	O	S_disease
.	.	O	O

A	a	O	O
chi-square	chi-square	O	O
test	test	O	O
was	was	O	O
used	used	O	O
to	to	O	O
assess	assess	O	O
the	the	O	O
statistical	statistical	O	O
significance	significance	O	O
of	of	O	O
results	results	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
Sixty	sixty	O	O
percent	percent	O	O
in	in	O	O
Group	group	O	O
A	a	O	O
developed	developed	O	O
postoperative	postoperative	O	O
emetic	emetic	O	O
symptoms	symptoms	O	O
,	,	O	O
headache	headache	O	S_disease
,	,	O	O
or	or	O	O
both	both	O	O
;	;	O	O
1	1	O	O
patient	patient	O	O
in	in	O	O
Group	group	O	O
B	b	O	O
developed	developed	O	O
symptoms	symptoms	O	O
.	.	O	O

CONCLUSIONS	conclusions	O	O
:	:	O	O
The	the	O	O
administration	administration	O	O
of	of	O	O
methylprednisolone	methylprednisolone	S_chemical	O
and	and	O	O
gentamicin	gentamicin	S_chemical	O
in	in	O	O
the	the	O	O
posterior	posterior	O	O
sub-Tenon	sub-tenon	O	O
's	's	O	O
space	space	O	O
was	was	O	O
related	related	O	O
to	to	O	O
a	a	O	O
high	high	O	O
incidence	incidence	O	O
of	of	O	O
side	side	O	O
effects	effects	O	O
including	including	O	O
nausea	nausea	O	S_disease
,	,	O	O
vomiting	vomiting	O	S_disease
,	,	O	O
and	and	O	O
headache	headache	O	S_disease
.	.	O	O

All	all	O	O
adverse	adverse	O	O
effects	effects	O	O
were	were	O	O
self-limiting	self-limiting	O	O
.	.	O	O

